PMID- 36765328 OWN - NLM STAT- MEDLINE DCOM- 20230214 LR - 20230214 IS - 1471-2415 (Electronic) IS - 1471-2415 (Linking) VI - 23 IP - 1 DP - 2023 Feb 10 TI - Development of an implantable collamer lens sizing model: a retrospective study using ANTERION swept-source optical coherence tomography and a literature review. PG - 59 LID - 10.1186/s12886-023-02814-7 [doi] LID - 59 AB - BACKGROUND: Optimal sizing for phakic intraocular lens (EVO-ICL with KS-AquaPort) implantation plays an important role in preventing postoperative complications. We aimed to formulate optimal lens sizing using ocular biometric parameters measured with a Heidelberg anterior segment optical coherence tomography (AS-OCT) device. METHODS: We retrospectively analyzed 892 eyes of 471 healthy subjects treated with an intraocular collamer lens (ICL) and assigned them to either the development (80%) or validation (20%) set. We built vault prediction models using the development set via classic linear regression methods as well as partial least squares and least absolute shrinkage and selection operator (LASSO) regression techniques. We evaluated prediction abilities based on the Bayesian information criterion (BIC) to select the best prediction model. The performance was measured using Pearson's correlation coefficient and the mean squared error (MAE) between the achieved and predicted results. RESULTS: Measurements of aqueous depth (AQD), anterior chamber volume, anterior chamber angle (ACA) distance, spur-to-spur distance, crystalline lens thickness (LT), and white-to-white distance from ANTERION were highly associated with the ICL vault. The LASSO model using the AQD, ACA distance, and LT showed the best BIC results for postoperative ICL vault prediction. In the validation dataset, the LASSO model showed the strongest correlation (r = 0.582, P < 0.001) and the lowest MAE (104.7 mum). CONCLUSION: This is the first study to develop a postoperative ICL vault prediction and lens-sizing model based on the ANTERION. As the measurements from ANTERION and other AS-OCT devices are not interchangeable, ANTERION may be used for optimal ICL sizing using our formula. Because our model was developed based on the East Asian population, further studies are needed to explore the role of this prediction model in different populations. CI - (c) 2023. The Author(s). FAU - Kim, Taein AU - Kim T AD - VISUWORKS, Seoul, South Korea. FAU - Kim, Su Jeong AU - Kim SJ AD - VISUWORKS, Seoul, South Korea. FAU - Lee, Bo Young AU - Lee BY AD - VISUWORKS, Seoul, South Korea. FAU - Cho, Hye Jin AU - Cho HJ AD - VISUWORKS, Seoul, South Korea. FAU - Sa, Beom Gi AU - Sa BG AD - VISUWORKS, Seoul, South Korea. FAU - Ryu, Ik Hee AU - Ryu IH AD - VISUWORKS, Seoul, South Korea. AD - Department of Refractive Surgery, B&VIIT Eye Center, 1317-23 Seocho-Dong, Seocho-Gu, Seoul, South Korea. FAU - Kim, Jin Kuk AU - Kim JK AD - VISUWORKS, Seoul, South Korea. AD - Department of Refractive Surgery, B&VIIT Eye Center, 1317-23 Seocho-Dong, Seocho-Gu, Seoul, South Korea. FAU - Lee, In Sik AU - Lee IS AD - Department of Refractive Surgery, B&VIIT Eye Center, 1317-23 Seocho-Dong, Seocho-Gu, Seoul, South Korea. FAU - Han, Eoksoo AU - Han E AD - Electronics and Telecommunications Research Institute (ETRI), Daejeon, South Korea. FAU - Kim, Hyungsu AU - Kim H AD - Yonsei Eye Clinic, Seoul, South Korea. FAU - Yoo, Tae Keun AU - Yoo TK AUID- ORCID: 0000-0003-0890-8614 AD - VISUWORKS, Seoul, South Korea. eyetaekeunyoo@gmail.com. AD - Department of Refractive Surgery, B&VIIT Eye Center, 1317-23 Seocho-Dong, Seocho-Gu, Seoul, South Korea. eyetaekeunyoo@gmail.com. LA - eng PT - Journal Article PT - Review DEP - 20230210 PL - England TA - BMC Ophthalmol JT - BMC ophthalmology JID - 100967802 SB - IM MH - Humans MH - Tomography, Optical Coherence/methods MH - Retrospective Studies MH - Lens Implantation, Intraocular/methods MH - Bayes Theorem MH - *Myopia/surgery MH - Anterior Chamber/diagnostic imaging MH - *Phakic Intraocular Lenses PMC - PMC9921691 OTO - NOTNLM OT - ANTERION OT - Implantable collamer lens OT - Lens sizing OT - Postoperative vault COIS- Ik Hee Ryu, Jin Kuk Kim, and Tae Keun Yoo are executives of VISUWORKS, Inc., which is a Korean Artificial Intelligence startup that provides medical machine learning solutions. Jin Kuk Kim is an executive of the Korea Intelligent Medical Industry Association. They received salaries or stocks as part of their standard compensation packages. The remaining authors declare no conflicts of interest. EDAT- 2023/02/12 06:00 MHDA- 2023/02/15 06:00 PMCR- 2023/02/10 CRDT- 2023/02/11 00:03 PHST- 2022/07/28 00:00 [received] PHST- 2023/02/09 00:00 [accepted] PHST- 2023/02/11 00:03 [entrez] PHST- 2023/02/12 06:00 [pubmed] PHST- 2023/02/15 06:00 [medline] PHST- 2023/02/10 00:00 [pmc-release] AID - 10.1186/s12886-023-02814-7 [pii] AID - 2814 [pii] AID - 10.1186/s12886-023-02814-7 [doi] PST - epublish SO - BMC Ophthalmol. 2023 Feb 10;23(1):59. doi: 10.1186/s12886-023-02814-7.